NanoAlvand is the entrance to Global Markets as a trusted Highly Potent Products manufacturer.
01 2NanoAlvand
02 2Aurobindo Pharma Limited
03 20Eli Lilly
04 1Health Biotech
05 3MSN Laboratories
01 2FCT
02 9Film Coated Tablet
03 2TABLET
04 8TABLET;ORAL
05 1Tablet
06 6Blank
01 2Allowed
02 3Approved
03 2Authorized
04 2DISCN
05 2Originator
06 2Prescription
07 6RX
08 9Blank
01 2BARICITINIB
02 2Intyma
03 8OLUMIANT
04 13Olumiant
05 1Unamity 2 mg
06 1Unamity 4 mg
07 1Blank
01 6Australia
02 2Canada
03 1India
04 2Iran
05 2South Africa
06 2Spain
07 3Sweden
08 2Switzerland
09 8USA
NanoAlvand is the entrance to Global Markets as a trusted Highly Potent Products manufacturer.
Regulatory Info :
Registration Country : Iran
Brand Name : Intyma
Dosage Form : Film Coated Tablet
Dosage Strength : 2MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Iran
NanoAlvand is the entrance to Global Markets as a trusted Highly Potent Products manufacturer.
Regulatory Info :
Registration Country : Iran
Brand Name : Intyma
Dosage Form : Film Coated Tablet
Dosage Strength : 4MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Iran
Regulatory Info : DISCN
Registration Country : USA
Brand Name : BARICITINIB
Dosage Form : TABLET;ORAL
Dosage Strength : 1MG
Packaging :
Approval Date : 2024-07-22
Application Number : 217542
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : BARICITINIB
Dosage Form : TABLET;ORAL
Dosage Strength : 2MG
Packaging :
Approval Date : 2024-07-22
Application Number : 217542
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : OLUMIANT
Dosage Form : TABLET;ORAL
Dosage Strength : 2MG
Packaging :
Approval Date : 2018-05-31
Application Number : 207924
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : OLUMIANT
Dosage Form : TABLET;ORAL
Dosage Strength : 1MG
Packaging :
Approval Date : 2019-10-08
Application Number : 207924
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : OLUMIANT
Dosage Form : TABLET;ORAL
Dosage Strength : 4MG
Packaging :
Approval Date : 2022-05-10
Application Number : 207924
Regulatory Info : RX
Registration Country : USA
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Olumiant
Dosage Form : Film Coated Tablet
Dosage Strength :
Packaging :
Approval Date : 15/09/2023
Application Number : 20220912000088
Regulatory Info : Approved
Registration Country : Sweden
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Olumiant
Dosage Form : Film Coated Tablet
Dosage Strength : 2mg
Packaging :
Approval Date : 13/02/2017
Application Number : 20160127000018
Regulatory Info : Approved
Registration Country : Sweden
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Olumiant
Dosage Form : Film Coated Tablet
Dosage Strength : 4mg
Packaging :
Approval Date : 13/02/2017
Application Number : 20160127000025
Regulatory Info : Approved
Registration Country : Sweden
Regulatory Info : Allowed
Registration Country : Switzerland
Brand Name : Olumiant
Dosage Form : Film Coated Tablet
Dosage Strength : 2mg
Packaging :
Approval Date : 19/06/2017
Application Number : 66215
Regulatory Info : Allowed
Registration Country : Switzerland
Regulatory Info : Allowed
Registration Country : Switzerland
Brand Name : Olumiant
Dosage Form : Film Coated Tablet
Dosage Strength : 4mg
Packaging :
Approval Date : 19/06/2017
Application Number : 66215
Regulatory Info : Allowed
Registration Country : Switzerland
Regulatory Info : Authorized
Registration Country : Spain
Brand Name : Olumiant
Dosage Form : Film Coated Tablet
Dosage Strength : 4MG
Packaging :
Approval Date : 2017-03-06
Application Number : 1161170010
Regulatory Info : Authorized
Registration Country : Spain
Regulatory Info : Authorized
Registration Country : Spain
Brand Name : Olumiant
Dosage Form : Film Coated Tablet
Dosage Strength : 2MG
Packaging :
Approval Date : 2017-03-06
Application Number : 1161170002
Regulatory Info : Authorized
Registration Country : Spain
Regulatory Info : Prescription
Registration Country : Canada
Brand Name : OLUMIANT
Dosage Form : TABLET
Dosage Strength : 2MG
Packaging : 14/28/30/90
Approval Date :
Application Number : 2480018
Regulatory Info : Prescription
Registration Country : Canada
Regulatory Info : Prescription
Registration Country : Canada
Brand Name : OLUMIANT
Dosage Form : TABLET
Dosage Strength : 4MG
Packaging :
Approval Date :
Application Number : 2544768
Regulatory Info : Prescription
Registration Country : Canada
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Tablet
Dosage Strength : 4MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Regulatory Info : RX
Registration Country : USA
Brand Name : OLUMIANT
Dosage Form : TABLET;ORAL
Dosage Strength : 1MG
Packaging :
Approval Date : 2025-08-08
Application Number : 217585
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : OLUMIANT
Dosage Form : TABLET;ORAL
Dosage Strength : 2MG
Packaging :
Approval Date : 2025-08-08
Application Number : 217585
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : OLUMIANT
Dosage Form : TABLET;ORAL
Dosage Strength : 4MG
Packaging :
Approval Date : 2025-08-08
Application Number : 217585
Regulatory Info : RX
Registration Country : USA
